{
  "ticker": "JNJ",
  "target_date": "2025-11-12",
  "actual_date": "2025-11-12",
  "collected_at": "2025-12-08T12:31:30.233792",
  "price": {
    "open": 192.14,
    "high": 194.32,
    "low": 191.85,
    "close": 193.16355895996094,
    "volume": 8803000,
    "change_1d_pct": 0.29,
    "change_7d_pct": 4.36,
    "change_30d_pct": 4.48
  },
  "technicals": {
    "rsi_14": 54.41,
    "sma_20": 188.69,
    "sma_50": 183.99,
    "macd": 1.173,
    "macd_signal": 1.028,
    "macd_histogram": 0.146,
    "bb_upper": 194.59,
    "bb_lower": 182.79,
    "price_vs_sma20_pct": 2.37,
    "price_vs_sma50_pct": 4.99,
    "volume_ratio": 1.16
  },
  "fundamentals": {
    "market_cap": 488147288064,
    "pe_ratio": 19.55695,
    "forward_pe": 19.114151,
    "price_to_book": 6.149574,
    "price_to_sales": 5.2973695,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.5,
    "pct_from_52w_low": 44.02
  },
  "macro": {
    "spy": {
      "price": 683.38,
      "change_1d_pct": 0.06,
      "change_7d_pct": 1.21
    },
    "vix": {
      "level": 17.51,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.07
    },
    "dollar_index": {
      "level": 99.48
    },
    "gold": {
      "price": 4204.4
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "BeOne, IBD Stock Of The Day, Breaks Out As It Takes On Cancer Giants J&J, AbbVie",
      "source": "Yahoo",
      "datetime": 1762983000,
      "summary": "BeOne Medicines is Wednesday's IBD Stock Of The Day. The IBD 50 biotech is breaking out after a record-breaking quarter.",
      "url": "https://finnhub.io/api/news?id=0ec01ad9e41bb4fd7ec1de62531c8902932ce19daec0b6c28afcd5143fee6b8e"
    },
    {
      "headline": "Walt Disney and 15 More Non-AI Stocks Worth a Look",
      "source": "Yahoo",
      "datetime": 1762978800,
      "summary": "Bank of America came up with 16 names that investors should consider buying. Renaissance Macro threw out a couple of sector ideas, too.",
      "url": "https://finnhub.io/api/news?id=52a90ea028f17e70133c9f9bc7c1790bb5077349e87842f2b419505a5c7d3a94"
    },
    {
      "headline": "Bayer Q3 Earnings Beat Estimates on Crop Science Business Gains",
      "source": "Yahoo",
      "datetime": 1762968360,
      "summary": "Bayer's Q3 earnings surged on Crop Science strength, offsetting pricing and currency headwinds across divisions.",
      "url": "https://finnhub.io/api/news?id=b3a5bb80958afeb7cfc7eeeab3190c1950659a1459abac91690c4277b7b53d6b"
    },
    {
      "headline": "Psoriatic Arthritis Market Trends and Competitive Analysis, 2025-2035 - Asia-Pacific and Latin America Offer New Growth Opportunities as Demand for Accessible Treatments Rises",
      "source": "Yahoo",
      "datetime": 1762966380,
      "summary": "Precision medicine and next-gen biologics are transforming patient care. Despite cost-related challenges, key players like AbbVie, Johnson & Johnson, and Bristol-Myers Squibb are leading innovations.Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The \"Psoriatic Arthritis Market - A Global and Regional Ana",
      "url": "https://finnhub.io/api/news?id=9675d39d3409fb7482f2eb8f23e8057265b285f2083906d3a549d6617c0d6c08"
    },
    {
      "headline": "How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?",
      "source": "Yahoo",
      "datetime": 1762966260,
      "summary": "ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.",
      "url": "https://finnhub.io/api/news?id=83dce1af9dce3d0933e007bd3b552e6362d4a409d78b10ec1d527bbe721d510d"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-10",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/xslF345X05/ownership.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    },
    {
      "form": "4",
      "date": "2025-10-20",
      "description": "xslF345X05/wk-form4_1761002033.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"
    },
    {
      "form": "8-K",
      "date": "2025-10-14",
      "description": "jnj-20251014.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/jnj-20251014.htm"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}